AN2 Therapeutics Inc (ANTX)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Total Assets (Quarterly): 97.69M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 97.69M |
| June 30, 2024 | 108.48M |
| March 31, 2024 | 121.26M |
| December 31, 2023 | 138.74M |
| September 30, 2023 | 153.81M |
| June 30, 2023 | 98.93M |
| Date | Value |
|---|---|
| March 31, 2023 | 91.08M |
| December 31, 2022 | 102.56M |
| September 30, 2022 | 110.01M |
| June 30, 2022 | 120.02M |
| March 31, 2022 | 120.50M |
| December 31, 2021 | 65.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
65.32M
Minimum
Dec 2021
153.81M
Maximum
Sep 2023
110.70M
Average
109.24M
Median
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Arbutus Biopharma Corp | 140.44M |
| GlycoMimetics Inc | 15.70M |
| FibroGen Inc | 264.42M |
| Cidara Therapeutics Inc | 162.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.02M |
| Shareholders Equity (Quarterly) | 87.67M |